Press Releases

Date	Title and Summary	Additional Formats
November 5, 2020	Vericel Reports Record Third Quarter Revenues and Net Income	View HTML PDF Version
November 2, 2020	Vericel to Present at Upcoming Investor Conferences	View HTML PDF Version
October 22, 2020	Vericel to Report Third-Quarter 2020 Financial Results on November 5, 2020	View HTML PDF Version
October 14, 2020	Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million	View HTML PDF Version
October 9, 2020	Vericel To Host Virtual Analyst and Investor Day on October 16, 2020	View HTML PDF Version
September 16, 2020	Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns	View HTML PDF Version
September 9, 2020	Vericel to Present at Multiple Upcoming Investor Conferences	View HTML PDF Version
September 4, 2020	Vericel to Present at the 18th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020	View HTML PDF Version
August 25, 2020	MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness	View HTML PDF Version
August 5, 2020	Vericel Reports Second Quarter 2020 Financial Results	View HTML PDF Version

Investor Relations